Loading...
Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis
Idiopathic pulmonary fibrosis is the most devastating diffuse fibrosing lung disease that remains refractory to therapy. Despite increasing evidence that protease-activated receptor 2 (PAR-2) contributes to fibrosis, its importance in pulmonary fibrosis is under debate. We addressed whether PAR-2 de...
Na minha lista:
| Udgivet i: | Mol Med |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Feinstein Institute Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4656197/ https://ncbi.nlm.nih.gov/pubmed/26147947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2015.00094 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|